David Cragg - Net Worth and Insider Trading

David Cragg Net Worth

The estimated net worth of David Cragg is at least $9 Million dollars as of 2024-04-28. David Cragg is the Chief HR & Admin Officer of Cytokinetics Inc and owns about 138,704 shares of Cytokinetics Inc (CYTK) stock worth over $9 Million. Details can be seen in David Cragg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Cragg has not made any transactions after 2021-11-09 and currently still holds the listed stock(s).

Transaction Summary of David Cragg

To

David Cragg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Cragg owns 1 companies in total, including Cytokinetics Inc (CYTK) .

Click here to see the complete history of David Cragg’s form 4 insider trades.

Insider Ownership Summary of David Cragg

Ticker Comapny Transaction Date Type of Owner
CYTK Cytokinetics Inc 2021-11-09 V.P. & Human Resources

David Cragg Latest Holdings Summary

David Cragg currently owns a total of 1 stock. David Cragg owns 138,704 shares of Cytokinetics Inc (CYTK) as of November 9, 2021, with a value of $9 Million.

Latest Holdings of David Cragg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2021-11-09 138,704 65.34 9,062,919

Holding Weightings of David Cragg


David Cragg Form 4 Trading Tracker

According to the SEC Form 4 filings, David Cragg has made a total of 5 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Cytokinetics Inc is the sale of 45,000 shares on November 9, 2021, which brought David Cragg around $2 Million.

Insider Trading History of David Cragg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Cragg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Cragg Ownership Network

Ownership Network List of David Cragg

No Data

Ownership Network Relation of David Cragg


David Cragg Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

David Cragg is the V.P. & Human Resources of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, David Cragg made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 322,500 shares made by Robert I Blum , a net sale of 135,675 shares made by Fady Ibraham Malik , and a net sale of 27,186 shares made by John T Henderson .

In summary, during the past 3 months, insiders sold 93,272 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 93,272 shares. During the past 18 months, 532,719 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 532,719 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

David Cragg Mailing Address

Above is the net worth, insider trading, and ownership report for David Cragg. You might contact David Cragg via mailing address: 280 East Grand Avenue, South San Francisco Ca 94080.

Discussions on David Cragg

No discussions yet.